#JustPublished!
#ECDC and @EMA_News collaborate on vaccine safety and effectiveness monitoring studies.
The joint Vaccine Monitoring Platform (VMP) will strengthen the continuous monitoring of the safety and effectiveness of #vaccines in the EU.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1600817766499782656
The first EU-funded study is already underway. It is a pre-exposure prophylaxis study to assess the effectiveness of Imvanex (#mpox #vaccine) in 15,000 individuals, which was launched by the VMP in October 2022.
Read more: https://www.ecdc.europa.eu/en/news-events/ecdc-and-ema-collaborate-vaccine-safety-and-effectiveness-monitoring-studies
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1600817776091766785